RELMADA THERAPEUTICS, INC. - Common stock, $0.001 par value per share (RLMD)

Q: What does CUSIP 75955J402 represent in this 13F holders report?

CUSIP 75955J402 is the security identifier for RLMD - RELMADA THERAPEUTICS, INC. - Common stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held RLMD - RELMADA THERAPEUTICS, INC. - Common stock, $0.001 par value per share in Q1 2026?

27 institutional investors reported RLMD - RELMADA THERAPEUTICS, INC. - Common stock, $0.001 par value per share for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: 75955J402

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common stock, $0.001 par value per share
Shares outstanding: 107,951,510
Total 13F shares: 5,444,076
Share change: +343,520
Total reported value: $37,890,685
Price per share: $6.96
Number of holders: 27
Value change: +$2,420,348
Number of buys: 9
Number of sells: 7

Quarterly Holders Quick Answers

What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 75955J402:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RLMD - RELMADA THERAPEUTICS, INC. - Common stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
JANUS HENDERSON GROUP PLC	13D/G 13F	Company	10%	7,439,415	$35,932,374	$0	30 Jan 2026	13D/G 13F
Squadron Capital Management LLC	13F 13D/G	Company · Squadron Master Fund LP	9.9% from 13D/G	6,700,000	$32,361,000	—	31 Dec 2025	13F 13D/G
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	4%	4,270,000	$20,624,100	—	31 Dec 2025	13F
Spruce Street Capital LP	13F 13D/G	Company	5.6% from 13D/G	4,086,181	$19,736,254	—	31 Dec 2025	13F 13D/G
Adage Capital Management, L.P.	13D/G	—	5.8%	4,270,000	$18,062,100	$0	31 Dec 2025	13D/G
MARSHALL WACE, LLP	13F	Company	3%	3,189,662	$15,406,068	—	31 Dec 2025	13F
Ikarian Capital, LLC	13F 13D/G	Company	4.8% from 13D/G	3,068,359	$14,820,175	—	31 Dec 2025	13F 13D/G
ORBIMED ADVISORS LLC	13F	Company	2.4%	2,610,600	$12,609,198	—	31 Dec 2025	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.8%	1,920,099	$9,274,078	—	31 Dec 2025	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	1.7%	1,880,006	$9,080,429	—	31 Dec 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.5%	1,673,017	$8,080,672	—	31 Dec 2025	13F
BRAIDWELL LP	13F	Company	1.5%	1,582,257	$7,642,301	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	1.2%	1,267,503	$6,122,039	—	31 Dec 2025	13F
VANGUARD GROUP INC	13F	Company	1.1%	1,203,307	$5,811,973	—	31 Dec 2025	13F
Sergio Traversa	3/4/5	Chief Executive Officer, Director	— mixed-class rows	3,298,000 mixed-class rows	$5,356,000	+$1,065,608	12 Dec 2025	3/4/5
Opaleye Management Inc.	13F	Company	0.87%	935,000	$4,516,050	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.79%	854,932	$4,131,406	—	31 Dec 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.77%	835,300	$4,034,499	—	31 Dec 2025	13F
Corient Private Wealth LLC	13F	Company	0.67%	719,582	$3,443,379	—	31 Dec 2025	13F
Maged Shenouda	3/4/5	Chief Financial Officer	— mixed-class rows	2,228,000 mixed-class rows	$3,296,000	+$1,245,268	12 Dec 2025	3/4/5
TWO SIGMA INVESTMENTS, LP	13F	Company	0.53%	572,835	$2,766,793	—	31 Dec 2025	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.51%	547,854	$2,646,135	—	31 Dec 2025	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.49%	526,718	$2,541,000	—	31 Dec 2025	13F
DIADEMA PARTNERS LP	13F	Company	0.36%	389,395	$1,880,778	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.36%	385,942	$1,864,100	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	0.3%	320,820	$1,549,561	—	31 Dec 2025	13F
AdvisorShares Investments LLC	13F	Company	0.3%	319,510	$1,543,233	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.25%	271,109	$1,309,456	—	31 Dec 2025	13F
PARSONS CAPITAL MANAGEMENT INC/RI	13F	Company	0.24%	263,000	$1,270,290	—	31 Dec 2025	13F
Persistent Asset Partners Ltd	13F	Company	0.21%	231,123	$1,116,324	—	31 Dec 2025	13F
Paul Edward Kelly	3/4/5	COO, Director	— mixed-class rows	1,730,295 mixed-class rows	$1,105,049	+$284,060	12 Dec 2025	3/4/5
DEUTSCHE BANK AG\	13F	Company	0.21%	224,846	$1,086,006	—	31 Dec 2025	13F
Point72 Asset Management, L.P.	13F	Company	0.17%	187,377	$905,031	—	31 Dec 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.17%	185,000	$893,550	—	31 Dec 2025	13F
Chuck Ence	3/4/5	CA and CO	— mixed-class rows	1,631,931 mixed-class rows	$888,648	+$402,530	12 Dec 2025	3/4/5
NORTHERN TRUST CORP	13F	Company	0.15%	165,453	$799,138	—	31 Dec 2025	13F
Informed Momentum Co LLC	13F	Company	0.15%	162,552	$785,126	—	31 Dec 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.15%	162,200	$783,426	—	31 Dec 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.14%	155,529	$751,205	—	31 Dec 2025	13F
Seven Fleet Capital Management LP	13F	Company	0.14%	154,109	$744,346	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.13%	145,000	$700,350	—	31 Dec 2025	13F
RBF Capital, LLC	13F	Company	0.13%	140,000	$676,200	—	31 Dec 2025	13F
Squarepoint Ops LLC	13F	Company	0.13%	138,233	$667,665	—	31 Dec 2025	13F
MGO ONE SEVEN LLC	13F	Company	0.09%	100,000	$483,000	—	31 Dec 2025	13F
SEI INVESTMENTS CO	13F	Company	0.09%	98,965	$478,001	—	31 Dec 2025	13F
ExodusPoint Capital Management, LP	13F	Company	0.06%	68,883	$332,705	—	31 Dec 2025	13F
OMERS ADMINISTRATION Corp	13F	Company	0.06%	65,900	$318,297	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	0.06%	62,357	$301,185	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	0.06%	60,000	$289,800	—	31 Dec 2025	13F
LMR Partners LLP	13F	Company	0.05%	55,600	$268,548	—	31 Dec 2025	13F

Institutional Holders of RELMADA THERAPEUTICS, INC. - Common stock, $0.001 par value per share (RLMD) as of Q1 2026

As of 31 Mar 2026, RELMADA THERAPEUTICS, INC. - Common stock, $0.001 par value per share (RLMD) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,444,076 shares. The largest 10 holders included VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD FIDUCIARY TRUST CO, PARSONS CAPITAL MANAGEMENT INC/RI, SEVEN GRAND MANAGERS, LLC, AdvisorShares Investments LLC, DEUTSCHE BANK AG\, JANE STREET GROUP, LLC, UBS Group AG, Hillsdale Investment Management Inc., and Persistent Asset Partners Ltd. This page lists 27 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

-50

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.